Subscription to Jana Medical’s 642,500 shares starts today on Nomu

06/11/2024 Argaam Special
Logo ofJana Medical Co.

Logo of Jana Medical Co.


Qualified investors started today, Nov. 6, subscribing to 642,500 shares of Jana Medical Co. on the Nomu-Parallel Market at SAR 40-44 apiece.

 

The shares on offer represent 25% of the company's pre-IPO capital of SAR 25.7 million, which is divided into 2.57 million shares, and 20% of the post-IPO capital of SAR 32.12 million, which will be divided into 3.21 million shares at SAR 10 par value each.

 

For More IPOs

 

The subscription period will run for nine days until Nov. 14.

 

The IPO of Jana Medical on Nomu today brings the total number of listings on the parallel market to 22 this year, following the cancellation of Al-Hokail Academy Specialized Digital Polyclinics Co.’s offering and the postponement of Kinan International for Real Estate Development Co.’s listing.

 

In June 2024, the Capital Market Authority (CMA) approved the company’s request to register and float its shares on Nomu.

 

The subscription is limited to certain categories of investors, including capital market institutions authorized to act on their own accounts. This is in addition to clients of capital market institutions authorized to carry out management operations, provided they are appointed under terms that enable them to take decisions related to accepting participation in the share offering and investment in Nomu on behalf of clients without prior consent.

 

The categories include the Saudi government, any government or international entity approved by the CMA, the Saudi market, any other financial market recognized by the CMA, or the Securities Depository Center Co. (Edaa).

 

They also include companies owned by the government, directly or through a portfolio managed by a person authorized to practice management operations. This is in addition to investment funds, companies, and funds established in the GCC countries.

 

Additionally, the qualified investors include any legal person entitled to open investment accounts inside the Kingdom and with Edaa, as well as natural persons allowed to open investment accounts inside the Kingdom and with Edaa, provided they fulfill certain criteria, including the below:

 

They should have executed transactions in the capital markets worth a minimum of SAR 40 million and at least 10 deals in each quarter during the past 12 months.

 

Natural persons should also have a net asset value of at least SAR 5 million and be working or have worked for at least three years in the financial sector.

 

They should hold a CMA-approved certificate in securities dealing and a professional certificate in the field of securities business, approved by an internationally recognized body.

 

The list of qualified investors includes also any other persons as defined by the CMA.

 

Company Profile

 

Established in 2014 in Riyadh, Jana Medical specializes in importing and supplying medical equipment to public and private hospitals across the Kingdom. The company also owns several medical agencies.

 

Company Profile 

Company 

Jana Medical Co.

Market 

Nomu Parallel Market

Core Activities 

Importing and supplying medical devices, equipment, and supplies

Pre-IPO Capital

SAR 25.7 mln

Number of shares 

2.57 mln shares

Post-IPO Capital

SAR 32.13 mln

Number of shares after IPO

3.21 mln

Share Par Value 

SAR 10/share

 

Company Shareholders

Shareholders

Before IPO

After IPO

Number of Shares

('000)​

Ownership (%)

Number of Shares

('000)​

Ownership (%)

Jana Investment Holding Co.

412.7

16.06%

412.7

12.85%

Eid Sultan Alotaibi

360.3

14.02%

360.3

11.21%

Meteb Sultan Alotaibi

8.9

0.35%

8.9

0.28%

Other shareholders owning less than 5% (7 shareholders)

238.9

9.29%

238.9

7.44%

The public owning less than 5% (814 shareholders)

1549.2

60.28%

1549.2

48.22%

The public (Qualified investors)​

--

--

642.5

20.00%

Total

2570

100%

3212.5

100%

 

IPO Summary

Issue Percentage

25% of pre-IPO capital

20% of post-IPO capital

Offered shares

642,500 shares

IPO Minimum Limit

10 shares

IPO Maximum Limit

157,400 shares

Offer period

Nov. 6-14, 2024

Final Allocation

Nov. 19, 2024

Surplus Refund (if any)​

Nov. 24, 2024

 

Additional Information

Financial Advisor

Afaq Capital

Lead Manager

Musharaka Capital

Receiving Entities​

Alistithmar Capital, Alinma Investment, SNB Capital, AlJazira Capital, Riyad Capital, ANB Capital, Albilad Capital, Al Rajhi Capital, Derayah Financial, Saudi Fransi Capital, SAB Invest, Alkhabeer Capital, Yaqeen Capital

 

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.